Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem-cell Transplant Outcomes

por Rondón, Gabriela, Saliba, Rima M., Chen, Julianne, Ledesma, Celina, Alousi, Amin M., Oran, Betul, Hosing, Chitra M., Kebriaei, Partow, Khouri, Issa F., Shpall, Elizabeth J., Popat, Uday R., Champlin, Richard E., Ciurea, Stefan O.
Publicado en Biol Blood Marrow Transplant (2017)

Management of Advanced and Relapsed/Refractory Extra-Nodal Natural Killer T-Cell Lymphoma (ENKL): An Analysis of Stem Cell Transplant and Chemotherapy Outcomes

por Brammer, Jonathan E., Chihara, Dai, Poon, L. Michelle, Caimi, Paolo, de Lima, Marcos, Ledesma, Celina, Rondon, Gabriela, Ciurea, Stefan O., Nieto, Yago, Fanale, Michele, Dabaja, Bouthaina, Maziarz, Richard T., Champlin, Richard E., Hosing, Chitra, Oki, Yasuhiro
Publicado en Clin Lymphoma Myeloma Leuk (2017)

GEMCITABINE, FLUDARABINE AND MELPHALAN AS A NOVEL REDUCED-INTENSITY CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

por Anderlini, Paolo, Saliba, Rima M., Ledesma, Celina, Chancoco, Christina, Alousi, Amin M, Shpall, Elizabeth J, Popat, Uday R., Hosing, Chitra M., Khouri, Issa F., Nieto, Yago, Ciurea, Stefan, Younes, Anas, Fanale, Michelle A., Acholonu, Sandra, Valverde, Rosamar, Champlin, Richard E.
Publicado en Leuk Lymphoma (2011)

Comparison of Outcomes at Two Institutions of Patients with Acute Lymphoblastic Leukemia Receiving Ex-Vivo T-Cell Depleted or Unmodified Allografts

por Hobbs, Gabriela S., Hamdi, Amir, Hilden, Patrick D., Goldberg, Jenna D., Poon, Michelle L., Ledesma, Celina, Devlin, Sean M., Rondon, Gabriela, Papadopoulos, Esperanza B., Jakubowski, Ann A., O'Reilly, Richard J., Champlin, Richard E., Giralt, Sergio, Perales, Miguel-Angel, Kebriaei, Partow
Publicado en Bone Marrow Transplant (2015)

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

por Tam, Constantine S., Bassett, Roland, Ledesma, Celina, Korbling, Martin, Alousi, Amin, Hosing, Chitra, Kebraei, Partow, Harrell, Robyn, Rondon, Gabriela, Giralt, Sergio A., Anderlini, Paolo, Popat, Uday, Pro, Barbara, Samuels, Barry, Hagemeister, Frederick, Medeiros, L. Jeffrey, Champlin, Richard E., Khouri, Issa F.
Publicado en Blood (2009)

Long-term follow-up of patients receiving allogeneic stem cell transplant for CLL: mixed T-cell chimaerism is associated with high relapse risk and inferior survival

por Thompson, Philip A., Stingo, Francesco, Keating, Michael J., Wierda, William G., O’Brien, Susan M., Estrov, Zeev, Ledesma, Celina, Rezvani, Katayoun, Qazilbash, Muzaffar, Shah, Nina, Parmar, Simrit, Popat, Uday, Anderlini, Paolo, Kebriaei, Partow, Champlin, Richard, Shpall, Elizabeth J., Hosing, Chitra M.
Publicado en Br J Haematol (2017)

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

por Saini, Neeraj, Marin, David, Ledesma, Celina, Delgado, Ruby, Rondon, Gabriela, Popat, Uday R., Bashir, Qaiser, Hosing, Chitra M., Nieto, Yago, Alousi, Amin M., Qazilbash, Muzaffar H., Ciurea, Stefan, Shpall, Elizabeth, Khouri, Issa, Kantarjian, Hagop, Jabbour, Elias, Ravandi, Farhad, Champlin, Richard E., Kebriaei, Partow
Publicado en Blood (2020)

Gemcitabine, fludarabine and melphalan for reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

por Anderlini, Paolo, Saliba, Rima M., Ledesma, Celina, Plair, Tamera, Alousi, Amin M., Hosing, Chitra M., Khouri, Issa F., Nieto, Yago, Popat, Uday R., Shpall, Elizabeth J, Fanale, Michelle A., Hagemeister, Frederick B., Oki, Yasuhiro, Neelapu, Saatva, Romaguera, Jorge E., Younes, Anas, Champlin, Richard E.
Publicado en Biol Blood Marrow Transplant (2016)

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation

por Khouri, Maria R., Jabbour, Elias J., Gulbis, Alison M., Turturro, Francesco, Ledesma, Celina, Korbling, Martin, Samuels, Barry I., Ahmed, Sairah, Alousi, Amin M., Ciurea, Stefan O., Marin, David, Patel, Krina K., Popat, Uday R., Bueso-Ramos, Carlos E., Bassett, Roland L., Khouri, Issa F.
Publicado en Biol Blood Marrow Transplant (2017)

Allogeneic Transplantation after Myeloablative Rituximab/BEAM +/− Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-up Results

por Chamoun, Kamal, Milton, Denái R., Ledesma, Celina, Young, Ken H., Jabbour, Elias J., Alatrash, Gheath, Anderlini, Paolo, Bashir, Qaiser, Ciurea, Stefan O., Marin, David, Molldrem, Jeffrey J., Olson, Amanda L., Oran, Betul, Popat, Uday R., Rondon, Gabriela, Champlin, Richard E., Gulbis, Alison M., Khouri, Issa F.
Publicado en Biol Blood Marrow Transplant (2019)